TrustBank’s Pfizer PFE Stock Holding History

TrustBank’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$103K	Hold	4,257	–	–	0.03%	158
2026 Q1	$120K	Buy	4,257 +1,168	+38%	+$31.1K	0.05%	139
2025 Q4	$76.9K	Buy	+3,089	New	+$77.9K	0.03%	131

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

TrustBank's PFE Position: Q2 2026 in Review

TrustBank held its Pfizer (PFE) position steady in Q2 2026 at 4,257 shares worth $103K. The position accounts for 0.03% of the portfolio, ranked #158.

TrustBank first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $120K in Q1 2026. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

TrustBank held 4,257 shares of Pfizer worth $103K as of Q2 2026.
TrustBank left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.03% of TrustBank's portfolio in Q2 2026, its #158 holding.
TrustBank first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
TrustBank's Pfizer position peaked at $120K in Q1 2026.
2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on TrustBank's 13F filing for Q2 2026, filed 20 Jul 2026.